Clinical Trial Update: Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br) [Phase 1]

View source ↗

Summary

Phase 1 trial investigating autologous aldehyde dehydrogenase-bright stem cells injected into the heart to promote therapeutic angiogenesis for coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aldehyde dehydrogenase-bright (ALDHbr) stem cells (ALDH-bright stem cells)

Snippet

Sponsor: Texas Heart Institute | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED | Results posted: 2015-11-23